$ONCY Oncolytics Biotech, Inc 25 % upside

NASDAQ:ONCY   Oncolytics Biotech Inc

On the verge of breaking the 100ma resistance which sits in confluence withe .382 fib as current barrier to a bullish move higher.25% upside
Average analysts price target $6.93 and BUY rating
Company profile
Oncolytics Biotech , Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.

⭐Email Newsletter > https://www.BullishCharts.com/

🔵Telegram Channel > https://t.me/BullishCharts

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.